Fundraising Fox

Michael Kocher

CEO at Xellia

Denmark

Find your path to Michael

97 people in our graph share verified history with Michael — schools, employers, funds. One of them is your warm intro.

Carol LynchunlockedMichael: together at Sandoz (2023)
Michael: together at Firmenich
×3Michael: together at Sandoz
×4Michael: together at Johannes Gutenberg University Mainz

CEO at Xellia

Intro paths

→

In turn, Michael can intro founders to Xellia's investors below.

Xellia's investors · 1

3i GroupLondon

Experience

  1. Xellia PharmaceuticalsCEOcurrent2023 — presentKopenhagen, Hovedstaden, Dänemark
  2. SandozSandoz Country President Austria2023
  3. Rowex Ltd.Board Member2019 — 2023Irland
  4. Austria HBHG Pharma GmbHChairman Of The Board Of Directors2018 — 2023Austria
  5. NovartisCEO Novartis Austria GmbH2018 — 2023
  6. NovartisGlobal President B2B Business2016 — 2023Kundl, Austria
  7. NovartisNos Country President Austria2018 — 2023
  8. NovartisGlobal Head Commercial Operations Anti- Infectives & API2012 — 2016Kundl, Austria
  9. Capitum ConsultingManaging Director2010 — 2012Frankfurt Am Main Area, Germany
  10. SymriseSenior Vice President Global Innovation2008 — 2010
  11. FirmenichGlobal Account Director2001 — 2008
  12. Reckitt BenckiserCategory Manager Product Development, Category Marketing Manager1997 — 2001

Skills & more

Cross-functional Team Leadership8Pharmaceutical Industry4Strategy11Business Strategy3Management17Flavors3Cosmetics2Consumer Products1Fragrance5Business Development1FMCG4Marketing7
+6 moreLeadershipKey Account ManagementPersonal CareMarket AnalysisProduct DevelopmentGlobal Marketing

From Michael's professional profile.

Frequently asked questions

Who is Michael Kocher?
CEO at Xellia
Where does Michael Kocher work?
Michael Kocher is CEO at Xellia.
Where did Michael Kocher go to school?
Michael Kocher studied at Johannes Gutenberg University Mainz (Master, Chemistry); University of Basel, Switzerland (Master, Marketing, Economics).

Same school

Also attended Johannes Gutenberg University Mainz16

Alexander KüppersInvestment Director at Statkraft VenturesJohn GrissomInvestor at Vector CapitalNatalie WisniewskiCompany Building Partner at Material ImpactThyra SeitzPartner and COO at Possible VenturesJohannaCommunications Manager at Realyze VenturesMichael HeldmannCIO Equity at Allianz Global Investors

+ 10 more

Also attended University of Basel, Switzerland45

Markus GemuendSenior Advisor at Adjuvant CapitalMichel BriejerManaging Partner at Thuja CapitalButrint AliuAnalyst at Pureos BioventuresNadine KuglerHead of Tech Communications at QAI VenturesDavide OttoliniCo-founder at Korify CapitalRobin LauberInvestor at Korify Capital

+ 39 more

Shared employers

Also worked at Xellia Pharmaceuticals5

Aleks EngelPartner at Novo HoldingsTue HoldalChief Technology Officer at Melt&MarbleAlexander SproedtChief Operations Officer at XelliaGaël BernardChief Commercial Officer at XelliaArt FioccoChief Quality Officer at Xellia

Also worked at Sandoz29

Nikita SharmaPrincipal at Versant VenturesCarol LynchAdvisor at Delin VenturesShreeram AradhyeInvestor at Novartis Venture FundMax PalkoPrincipal at Rockaway VenturesIain RossNon-Executive Director at TernAngela ZubelChief Development Officer, Research & Development at Debiopharm Innovation Fund

+ 23 more

Also worked at Novartis330

Rebecca JamesInvestor at Index VenturesScott BillerInvestor at GV (Google Ventures)Freya Svedberg-KeatingInvestor at MedicxiAndrea AmadorCompliance Manager at Inveready Technology Investment GroupAbbie CelnikerInvestor at Third Rock VenturesJesper GromadaInvestor at Third Rock Ventures

+ 324 more

Also worked at Symrise2

Vailesh RamAssociate at Lavni VenturesHarrison YoonExecutive Officer, Director at Kula Bio